Prodrugs are described whose structures have a oligopeptide chain which is substituted by a nucleophilic chemotherapeutic residue at the a-position. The products have increased cell membrane permeability and beneficial physico-chemical properties.
所述原药的结构是在 a 位被亲核化疗残基取代的低聚肽链。这些产品具有更高的细胞膜渗透性和有益的物理
化学特性。